Nanomedicine embraces cancer radio-immunotherapy: mechanism, design, recent advances, and clinical translation-Reference-Cited by-同舟云学术

Nanomedicine embraces cancer radio-immunotherapy: mechanism, design, recent advances, and clinical translation

Published:2023 Issue:1 Volume:52 Page:47-96
ISSN:0306-0012
Container-title:Chemical Society Reviews
language:en
Short-container-title:Chem. Soc. Rev.

Author:

Li Haonan¹^ORCID,Luo Qiang¹,Zhang Hu²^ORCID,Ma Xuelei¹,Gu Zhongwei¹^ORCID,Gong Qiyong¹³,Luo Kui¹³^ORCID

Affiliation:

1. Department of Radiology, Department of Biotherapy, Huaxi MR Research Center (HMRRC), Cancer Center, Frontiers Science Center for Disease-Related Molecular Network, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, No. 37 Guoxue Alley, Chengdu 610041, China

2. Amgen Bioprocessing Centre, Keck Graduate Institute, Claremont, CA 91711, USA

3. Functional and Molecular Imaging Key Laboratory of Sichuan Province and Research Unit of Psychoradiology, Chinese Academy of Medical Sciences, Chengdu 610041, China

Abstract

This review overviews the landscape of nanomedicine-aided cancer radio-immunotherapy in a “from bench to clinic” manner.

Funder

National Natural Science Foundation of China

Sichuan University

Publisher

Royal Society of Chemistry (RSC)

Subject

General Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2023/CS/D2CS00437B

Reference493 articles.